AHCO AdaptHealth Corp.

Nasdaq adapthealth.com


$ 9.66 $ 0.20 (2.11 %)    

Tuesday, 21-Oct-2025 15:29:16 EDT
QQQ $ 611.79 $ 0.25 (0.04 %)
DIA $ 469.68 $ 2.59 (0.55 %)
SPY $ 671.85 $ 0.35 (0.05 %)
TLT $ 92.00 $ 0.01 (0.02 %)
GLD $ 378.04 $ -8.60 (-2.22 %)
$ 9.47
$ 9.47
$ 9.65 x 185
$ 9.66 x 350
$ 9.48 - $ 9.68
$ 7.11 - $ 11.63
909,964
na
1.28B
$ 0.97
$ 15.90
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 08-07-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 03-06-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-29-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 adapthealth-narrows-fy2025-sales-guidance-from-3150b-3290b-to-3180b-3260b-vs-3252b-est

Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025, as follows:Net revenue of $3.18 bill...

 adapthealth-closes-disposition-of-certain-infusion-assets-in-wellness-at-home-segment-uses-sale-proceeds-to-pay-down-65m-in-debt

AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-center...

 truist-securities-maintains-buy-on-adapthealth-lowers-price-target-to-13

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $1...

 rbc-capital-maintains-outperform-on-adapthealth-lowers-price-target-to-13

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $14 t...

 adapthealth-lowers-fy2025-sales-guidance-from-322b-336b-to-318b-332b-vs-327b-est-sees-adjusted-ebitda-of-665m-to-705m-prior-670m-to-710m

Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025 to account for the disposition of cer...

 adapthealth-q1-eps-005-misses-004-estimate-sales-77788m-beat-76477m-estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.04 b...

 baird-maintains-outperform-on-adapthealth-raises-price-target-to-16

Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $14 to $16.

 canaccord-genuity-maintains-buy-on-adapthealth-raises-price-target-to-14

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $13 ...

 rbc-capital-maintains-outperform-on-adapthealth-raises-price-target-to-14

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $11 t...

 truist-securities-maintains-buy-on-adapthealth-raises-price-target-to-14

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $1...

 adapthealth-q4-2024-gaap-eps-034-beats-027-estimate-sales-85665m-beat-82919m-estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.27 by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION